524564 GAYATRIBI

Gayatri BioOrganics Share Price

 

 

Start SIP in GAYATRIBI

Start SIP

Performance

  • Low
  • ₹13
  • High
  • ₹14
  • 52 Week Low
  • ₹5
  • 52 Week High
  • ₹20
  • Open Price₹13
  • Previous Close₹13
  • Volume14,412
  • 50 DMA₹13.90
  • 100 DMA₹12.92
  • 200 DMA₹11.30

Investment Returns

  • Over 1 Month -23.51%
  • Over 3 Month + 9.94%
  • Over 6 Month + 52.98%
  • Over 1 Year + 94.29%

Smart Investing Starts Here Start SIP with Gayatri BioOrganics for Steady Growth!

Invest Now

Gayatri BioOrganics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -132.4
  • PEG Ratio
  • 22
  • Market Cap Cr
  • 107
  • P/B Ratio
  • -2.9
  • Average True Range
  • 0.9
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.27
  • RSI
  • 46.56
  • MFI
  • 38.69

Gayatri BioOrganics Financials

Gayatri BioOrganics Technicals

EMA & SMA

Current Price
₹13.60
+ 0.64 (4.94%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹13.99
  • 50 Day
  • ₹13.90
  • 100 Day
  • ₹12.92
  • 200 Day
  • ₹11.30

Resistance and Support

13.24 Pivot Speed
  • R3 15.05
  • R2 14.33
  • R1 13.96
  • S1 12.87
  • S2 12.15
  • S3 11.78

Gayatri BioOrganics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-07-29 Quarterly Results
2025-05-28 Audited Results
2025-01-20 Quarterly Results
2024-11-11 Quarterly Results

Gayatri BioOrganics F&O

Gayatri BioOrganics Shareholding Pattern

21.59%
0.65%
0.01%
52.91%
24.84%

Gayatri BioOrganics FAQs

Gayatri BioOrganics share price is ₹13 As on 26 January, 2026 | 10:51

The Market Cap of Gayatri BioOrganics is ₹107.2 Cr As on 26 January, 2026 | 10:51

The P/E ratio of Gayatri BioOrganics is -132.4 As on 26 January, 2026 | 10:51

The PB ratio of Gayatri BioOrganics is -2.9 As on 26 January, 2026 | 10:51

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23